Business Wire

PayRetailers Strengthens Its Operations in Latin America

4.5.2022 12:15:00 CEST | Business Wire | Press Release

Share

Payment technology solutions have found fertile ground for expansion in Latin America given the lack of financial inclusion in the region, which in turn has put firms in this industry in a favorable business position. Latin America is home to around 300 million digital shoppers, a figure that is expected to grow by more than 20 percent by 2025.

PayRetailers, the main LATAM Fintech's payments specialist, announced the opening of new offices in Peru, a move that will help the company be closer to its customer base and consolidate its presence in one of the fastest growing markets. Moreover, it will enable the company to serve strategic markets throughout Latin America and innovate alongside dynamic financial service providers to offer differentiated and innovative digital experiences to its customers.

Given the myriad opportunities in the region, the company continues to expand its team and technology to build a robust and inclusive payments infrastructure. With a broad offering of card payment solutions and local alternative methods for global businesses expanding into Latin America, today PayRetailers has teams of more than 20 different nationalities and operations in more than 15 countries in Europe and Latin America.

New strategic acquisitions within the region

The company recently acquired two online payment platforms, Paygol of Chile and Pago Digital of Colombia. The two acquisitions strengthen PayRetailers' broad and deep move to tap into the potential of e-commerce payments in Latin America. The agreement gives Paygol and Pago Digital access to PayRetailers' extensive technical expertise, marketing resources and financial investment to grow at a scale.

Understanding the complexities and challenges specific to the continent's markets is one of the biggest challenges the companies looking to expand their operations in the Latin American market need to face. The acquisitions reinforce PayRetailers' position as the leading Fintech payments specialist for Latin America and efforts to simplify B2B e-commerce across the region.

Paygol CEO, Carlos Varas, said, "Paygol believes passionately in the power of local knowledge to bridge international borders. It's a notion we share with PayRetailers as we move forward together to truly unlock the potential of e-commerce businesses across Latin America."

Pago Digital CEO William Talero said, "Pago Digital was founded on a vision of simple and accessible online payments. We have come a long way in 10 years and now we are excited to climb to the next level with PayRetailers: sharing technologies, experience and expertise to bring our customers ever greater opportunities."

Royal Park Partners acted as exclusive financial and strategic advisor to PayRetailers on the acquisition of Pago Digital.

Challenges Fintech companies face for the sake of financial inclusion in Latin America

The Fintech ecosystem in Latin America is performing better year after year; by 2020, there were close to 1,500 parties, including startups, regulators and traditional companies, such as banks. As new technologies such as cryptocurrencies or the metaverse take hold, these organizations have greater challenges to take on as part of the fourth industrial revolution.

According to a survey published in January 2022 by VISA, the growth of the Fintech ecosystem in Latin America can be confirmed by taking into account the 52% increase in financing to the sector.

Latin America experienced the fastest growing e-commerce retail sales boom in the world during 2020. In Mexico, e-commerce grossed nearly 316 billion pesos (US$15 billion) during the year, representing 81% annual growth and accounting for 9% of total retail sales, according to the Mexican online sales association AMVO. The pandemic showed Mexico what it means to be unprepared for the future, making major changes in the daily lives of Mexicans, living in a reality where going out on the street was no longer an option for many people.

To meet the demand, during 2022, Fintech and non-banking companies have been launching solutions such as e-wallets, credit cards and prepaid cards, especially in underserved markets. Digital payments, including through new forms such as QR codes, instant payments or contactless payments, should proliferate among buyers and sellers.

Also of note are regulatory updates and adoption of the blockchain ecosystem in Chile, Argentina, Brazil, Colombia, Costa Rica, El Salvador, Mexico, and Venezuela. El Salvador becomes the first Latin American country to adopt Bitcoin as an official currency as of September 7, 2021, a movement that has been gaining momentum throughout Latin America. As regulation matures around the world, Latin America is proving to be a thriving ground for blockchain development.

With a focus on expanding its customer base and exponentially elevating product reach over the next decade, PayRetailers aims to strengthen verticals such as digital services and e-commerce. Its strategy has allowed it to offer services and occupy spaces not served by traditional payment providers, a player that has to be watched closely in the coming years.

About PayRetailers

PayRetailers is a leading online payment services provider, dedicated to creating a fast and simple payment process for merchants and shoppers. The company offers a full range of payment solutions to help e-commerce companies accept online payments through a single API integration.

A clear understanding of consumer behavior and spending in their specific sector will be the difference between success and failure for merchants looking to expand internationally across certain e-commerce verticals. By accepting local payment methods, PayRetailers allows anyone to make online purchases, even if they don't have credit or debit cards.

PayRetailers is headquartered in Spain, with regional offices in Mexico, Argentina, Brazil, Chile, Colombia, Uruguay and Peru.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Catalina Rivera
press@payretailers.com

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press Release

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press Release

Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522186975/en/ Adam Plich, CEO and Co-Founder of Avanzanite Bioscience. “Thalassaemia is a complex, chronic and multisystem disease characterised by anaemia, ineffective erythropoiesis and haemo

ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press Release

OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future

Enhertu ® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press Release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority

Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press Release

Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, signalling a shift in health systems from late-stage treatment to earlier intervention. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522587414/en/ Selected from 393 submissions across 68 countries, the winning teams were recognised through the inaugural ‘Future Health Challenge 2026: Building Anticipatory Health Systems through Population Sensing’, delivered by Future Health – A Global Initiative by Abu Dhabi in collaboration with MIT Solve. Health systems globally are facing rising costs and persistent delays in diagnosis, with many conditions still identified only after symptoms become severe. At the sam

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye